Bipolar disorder is a mood condition defined by alternating episodes of elevated and depressed mood that vary in severity and duration. The diagnostic framework in the DSM-5, guided by David J. Kupfer University of Pittsburgh, distinguishes episodes of mania, hypomania, and major depression, and identifies patterns and functional impact that determine subtype and treatment approach. Presentation can differ across individuals, cultures, and life stages, so clinicians rely on a combination of symptom clusters, history, and collateral information.
Manic and hypomanic symptoms
During mania and hypomania people experience a distinct period of abnormally elevated, expansive, or irritable mood accompanied by increased energy or activity. Common signs include decreased need for sleep, pressured or rapid speech, racing thoughts or flight of ideas, and inflated self-esteem or grandiosity. Behavior often becomes goal-directed or restless, with increased talkativeness and distractibility; impulsive decisions such as excessive spending, risky sexual behavior, or reckless driving are frequent. In mania, impairment in social or occupational functioning or psychotic symptoms may occur, whereas hypomania is a less severe form that lacks marked functional decline or psychosis but still represents a clear change from usual behavior. Because hypomanic episodes may feel subjectively positive, they are sometimes missed by patients and clinicians alike.
Depressive and mixed symptoms
Depressive episodes mirror major depressive disorder with prominent low mood, loss of interest or pleasure, changes in appetite or weight, altered sleep (insomnia or hypersomnia), psychomotor slowing or agitation, fatigue, and diminished concentration. Excessive guilt or feelings of worthlessness and recurrent thoughts of death or suicide are particularly important to identify. Episodes with mixed features—where symptoms of mania and depression occur simultaneously—carry a high risk of impulsivity and suicidality. Clinical scholars such as Kay Redfield Jamison Johns Hopkins University have emphasized the elevated suicide risk in bipolar disorder and the need for thorough assessment and safety planning.
Etiology is multifactorial. Genetic predisposition, neurochemical and circadian rhythm disruptions, and environmental triggers like stress or substance use interact to provoke episodes. Research including work by Michael Berk Deakin University points to biological processes, including neuroinflammation and neuroplasticity changes, that may underlie mood dysregulation. No single cause explains every case; families, trauma history, and access to care all shape the course of illness.
Consequences extend beyond mood symptoms. Recurrent episodes can impair relationships, employment, and physical health, and comorbidities such as substance use, anxiety disorders, and cardiometabolic conditions are common. Cultural factors influence how symptoms are described and whether help is sought; in some communities emotional distress is expressed through physical complaints or interpreted within spiritual frameworks, affecting diagnosis and engagement with treatment. Environmental factors such as disrupted sleep, seasonal changes, or stimulant use frequently precipitate relapses.
Because bipolar disorder has specific treatment implications and risks, including suicide, early recognition and a comprehensive clinical evaluation are important. Evidence-based management typically combines pharmacotherapy and psychosocial interventions and is tailored to episode type, severity, and individual context. Accurate symptom identification is the first step toward effective, culturally sensitive care.